UNIVERSITY OF MASSACHUSETTS

Their core work

The University of Massachusetts (Amherst) is a major US public research university that participates in EU Horizon 2020 exclusively through Marie Skłodowska-Curie researcher mobility programmes. Rather than leading EU consortia, individual UMass labs host or collaborate with European researchers across a wide range of disciplines — from chromosome biology and metabolic physiology to nanocomputing and social sciences. Their H2020 footprint reflects the breadth of a large research university where multiple independent labs engage with European partners on a project-by-project basis.

What they specialise in

How they've shifted over time

Early H2020 involvement (2015-2018) was highly diverse with no discernible thematic focus — projects spanned nanocomputing, reproductive health, bio-inspired materials, and social sciences, none producing recorded keywords. The most recent projects (2021-2024) show a sharper biomedical orientation, concentrating on molecular biology (chromatin structure, DNA replication) and metabolic physiology (brown fat, glucose metabolism). This shift likely reflects which individual labs most actively engaged with European MSCA programmes rather than a deliberate institutional pivot.

Recent projects point toward life sciences and biomedical research, suggesting future European collaborations will likely involve genomics, chromatin biology, or metabolic disease labs at UMass.

How they like to work

UMass participates exclusively as a third-party partner — never as coordinator or formal consortium member — which is typical for non-EU institutions in MSCA programmes. They have worked with 36 different partners across 14 countries, indicating a broad but shallow network where each project brings entirely new collaborators. This means UMass labs are accessible and open to new partnerships but there is no single institutional gatekeeper; engagement happens at the individual lab level.

UMass has collaborated with 36 unique partners across 14 countries through its MSCA involvement, reflecting a wide but non-concentrated European network. As a US-based third party, their connections span multiple EU member states without a strong geographic bias.

What sets them apart

As a large US public research university, UMass Amherst brings American research capacity and infrastructure to European consortia — a valuable asset for MSCA mobility programmes seeking transatlantic researcher exchange. Their participation across six unrelated disciplines demonstrates that many independent labs are willing to host European researchers, making them a flexible partner for varied scientific domains. For consortium builders, UMass offers a credible non-EU partner with strong research infrastructure, though engagement requires identifying the right lab rather than going through a central EU projects office.

Highlights from their portfolio

• COSMOS
  Most recent and scientifically specific project — focuses on S-phase chromosome conformation using Hi-C and replication timing analysis, signalling strong genomics capability.
• GLUCOBAT
  Addresses the commercially relevant area of brown adipose tissue and metabolic regulation, with potential applications in obesity and diabetes research.
• PlaMatSu
  An MSCA training network on plant-inspired materials and surfaces — sits at the intersection of biology and materials engineering, a distinctive applied-science niche.